Department of Medicine Research
PROTECT-APT 1 Study
Early Treatment and Post-Exposure Prophylaxis of COVID-19 - Adaptive Platform Trial (PROTECT-APT 1)
AGE: 18+ years old
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
TYPE: Interventional Study
CONDITION: SARS-CoV-2, COVID
CONDITION: SARS-CoV-2, COVID
LOCATIONS: UH Cleveland Medical Center and other locations
Study Purpose
The purpose of this research study is to test the ability of an investigational study drug to shorten and reduce a COVID-19 infection. In addition, researchers will study how well the study drug works against the virus that causes COVID-19 and continue to monitor the safety of the study drug.
Who Can Participate
Participants 18 years and older diagnosed with COVID be eligible for this study.
- 2024-01447